A

host of burgeoning fields in biomedicine — from personalized therapies and CRISPR gene editing to targeted tumor diagnostics — depend on the ability of labs to synthesize DNA on demand, cheaply and reliably.

Innovators in the field like San Francisco-based Twist Bioscience and Cambridge, Mass.-based Gen 9 use silicon wafers and microarrays to scale up the process, but are still using the same basic chemical techniques pioneered some 30 years ago. Now, a tiny ten-person startup in San Diego called Molecular Assemblies Inc. is nudging into the field with an entirely new process that uses enzymes instead of chemicals to create DNA. The technique was co-invented by one of the company’s founders, William Efcavitch, who also helped pioneered the chemical technique for synthesizing DNA that is in widespread use today.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.

Recommended Stories